Abcellera Biologics shares owned by UBS Group
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14k | 2.5k | 5.71 |
| 2023-06-30 | $86k | 13k | 6.46 |
| 2023-03-31 | $504k | 67k | 7.54 |
| 2022-12-31 | $752k | 74k | 10.13 |
| 2022-09-30 | $3.4M | 344k | 10.00 |
| 2022-06-30 | $440k | 41k | 10.64 |
| 2022-03-31 | $609k | 62k | 9.76 |
| 2021-12-31 | $1.1M | 79k | 14.29 |
| 2021-09-30 | $1.3M | 63k | 20.03 |
| 2021-06-30 | $884k | 41k | 21.54 |
| 2021-03-31 | $104k | 3.1k | 33.89 |
| 2020-12-31 | $0 | 8 | 0.00 |